Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Proteasome Inhibitors and a Fusicoccin Derivative (ISIR-042) Cooperatively Inhibit Proliferation of Myeloma Cells through Induction of C/EBP-Homologous Protein (CHOP/GADD153)

Takaaki Miyake, Yoshio Honma, Tsutomu Takahashi, Koshi Kawakami, Takahiro Okada, Satoshi Kumanomido, Fumiyoshi Ikejiri, Yumi Jo, Chie Onishi, Ichiro Moriyama, Inoue Masaya, Ritsuro Suzuki, MD PhD, Junji Suzumiya, MD PhD

Blood (2016) 128 (22): 5657.

https://doi.org/10.1182/blood.V128.22.5657.5657

Published: 2016

Journal Articles

Cotylenin Α, a Fusicoccane Diterpene Glycoside with a Complex Sugar Moiety, and Vincristine Synergistically Inhibit the Growth of Myeloma Cell in Vitro and in Vivo

Tsutomu Takahashi, MD PhD, Yoshio Honma, PhD, Koshi Kawakami, MDPhD, Junji Suzumiya

Blood (2014) 124 (21): 5721.

https://doi.org/10.1182/blood.V124.21.5721.5721

Published: 2014

Journal Articles

Inverse Correlation of NM23 Expression with Lysophosphatidic Acid Receptor EDG2/ lpa1 Expression of Human Leukemia Cells during Myeloid Differentiation Induced by All -Trans Retinoic Acid

Junko Okabe-Kado, PhD, Takashi Kasukabe, PhD, Yoshio Honma, PhD, Yasuhiko Kaneko, PhD, MD

Blood (2008) 112 (11): 4490.

https://doi.org/10.1182/blood.V112.11.4490.4490

Published: 2008

Journal Articles

Effects of Extracellular NM23 Protein on In Vitro Survival of Acute Myeloid Leukemia Cells and Normal Peripheral Blood Mononuclear Cells.

Junko Okabe-Kado, PhD, Takashi Kasukabe, PhD, Hirofumi Kobayashi, MD, Nobuo Maseki, MD, Yoshio Honma, PhD, Yasuhiko Kaneko, MD

Blood (2006) 108 (11): 1934.

https://doi.org/10.1182/blood.V108.11.1934.1934

Published: 2006

Journal Articles

Analysis of Factors Involved in Malignant Progression of Anaplastic Large Cell Lymphoma Kinase (ALK) -Negative Anaplastic Large Cell Lymphoma.

Tsuyoshi Nakamaki, MD, Takashi Maeda, MD, Hidetoshi Nakashima, MD, Masamichi Hattori, MD, Takako Usui, MD, Shigeru Tomoyasu, MD, Yoshio Honma, PhD

Blood (2004) 104 (11): 3272.

https://doi.org/10.1182/blood.V104.11.3272.3272

Published: 2004

Journal Articles

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

Yasuhiko Kano, Miyuki Akutsu, Saburo Tsunoda, Hiroyuki Mano, Yuko Sato, Yoshio Honma, Yusuke Furukawa

Blood (2001) 97 (7): 1999–2007.

https://doi.org/10.1182/blood.V97.7.1999

Published: 2001

Journal Articles

Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma

Nozomi Niitsu, Junko Okabe-Kado, Masataka Okamoto, Toshiyuki Takagi, Takashi Yoshida, Sadao Aoki, Masami Hirano, Yoshio Honma

Blood (2001) 97 (5): 1202–1210.

https://doi.org/10.1182/blood.V97.5.1202

Published: 2001

Journal Articles

Antileukemic efficacy of 2′-deoxycoformycin in monocytic leukemia cells

Nozomi Niitsu, Yuri Yamamoto-Yamaguchi, Takashi Kasukabe, Junko Okabe-Kado, Masanori Umeda, Yoshio Honma

Blood (2000) 96 (4): 1512–1516.

https://doi.org/10.1182/blood.V96.4.1512

Published: 2000

Journal Articles

Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia

Nozomi Niitsu, Junko Okabe-Kado, Michihiro Nakayama, Naoki Wakimoto, Akiko Sakashita, Nobuo Maseki, Kazuo Motoyoshi, Masanori Umeda, Yoshio Honma

Blood (2000) 96 (3): 1080–1086.

https://doi.org/10.1182/blood.V96.3.1080

Published: 2000

Journal Articles

Prognostic Implications of the Differentiation Inhibitory Factor nm23-H1 Protein in the Plasma of Aggressive Non-Hodgkin’s Lymphoma

Nozomi Niitsu, Junko Okabe-Kado, Takashi Kasukabe, Yuri Yamamoto-Yamaguchi, Masanori Umeda, Yoshio Honma

Blood (1999) 94 (10): 3541–3550.

https://doi.org/10.1182/blood.V94.10.3541.422k15_3541_3550

Published: 1999

Journal Articles

Human Monocytoid Leukemia Cells Are Highly Sensitive to Apoptosis Induced by 2′-Deoxycoformycin and 2′-Deoxyadenosine: Association With dATP-Dependent Activation of Caspase-3

Nozomi Niitsu, Yuri Yamaguchi, Masanori Umeda, Yoshio Honma

Blood (1998) 92 (9): 3368–3375.

https://doi.org/10.1182/blood.V92.9.3368

Published: 1998

Journal Articles

Induction of Differentiation in Acute Promyelocytic Leukemia Cells by 9- cis Retinoic Acid α-Tocopherol Ester (9- cis Tretinoin Tocoferil)

Makoto Makishima, Kazuhiko Umesono, Koichi Shudo, Tomoki Naoe, Kenji Kishi, Yoshio Honma

Blood (1998) 91 (12): 4715–4726.

https://doi.org/10.1182/blood.V91.12.4715

Published: 1998

Journal Articles

Evaluation by Multivariate Analysis of the Differentiation Inhibitory Factor nm23 as a Prognostic Factor in Acute Myelogenous Leukemia and Application to Other Hematologic Malignancies

Akihiro Yokoyama, Junko Okabe-Kado, Naoki Wakimoto, Hirofumi Kobayashi, Akiko Sakashita, Nobuo Maseki, Tsuyoshi Nakamaki, Ken-ichiro Hino, Shigeru Tomoyasu, Nobuyoshi Tsuruoka, Kazuo Motoyoshi, Naokazu Nagata, Yoshio Honma

Blood (1998) 91 (6): 1845–1851.

https://doi.org/10.1182/blood.V91.6.1845

Published: 1998

Journal Articles

TRA1, a Novel mRNA Highly Expressed in Leukemogenic Mouse Monocytic Sublines But Not in Nonleukemogenic Sublines

Takashi Kasukabe, Junko Okabe-Kado, Yoshio Honma

Blood (1997) 89 (8): 2975–2985.

https://doi.org/10.1182/blood.V89.8.2975

Published: 1997

NARROW

Proteasome Inhibitors and a Fusicoccin Derivative (ISIR-042) Cooperatively Inhibit Proliferation of Myeloma Cells through Induction of C/EBP-Homologous Protein (CHOP/GADD153)

Cotylenin Α, a Fusicoccane Diterpene Glycoside with a Complex Sugar Moiety, and Vincristine Synergistically Inhibit the Growth of Myeloma Cell in Vitro and in Vivo

Inverse Correlation of NM23 Expression with Lysophosphatidic Acid Receptor EDG2/ lpa1 Expression of Human Leukemia Cells during Myeloid Differentiation Induced by All -Trans Retinoic Acid

Effects of Extracellular NM23 Protein on In Vitro Survival of Acute Myeloid Leukemia Cells and Normal Peripheral Blood Mononuclear Cells.

Analysis of Factors Involved in Malignant Progression of Anaplastic Large Cell Lymphoma Kinase (ALK) -Negative Anaplastic Large Cell Lymphoma.

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma

Antileukemic efficacy of 2′-deoxycoformycin in monocytic leukemia cells

Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia

Prognostic Implications of the Differentiation Inhibitory Factor nm23-H1 Protein in the Plasma of Aggressive Non-Hodgkin’s Lymphoma

Human Monocytoid Leukemia Cells Are Highly Sensitive to Apoptosis Induced by 2′-Deoxycoformycin and 2′-Deoxyadenosine: Association With dATP-Dependent Activation of Caspase-3

Induction of Differentiation in Acute Promyelocytic Leukemia Cells by 9- cis Retinoic Acid α-Tocopherol Ester (9- cis Tretinoin Tocoferil)

Evaluation by Multivariate Analysis of the Differentiation Inhibitory Factor nm23 as a Prognostic Factor in Acute Myelogenous Leukemia and Application to Other Hematologic Malignancies

TRA1, a Novel mRNA Highly Expressed in Leukemogenic Mouse Monocytic Sublines But Not in Nonleukemogenic Sublines

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only